Product Introduction

Phytomenadione is a form of vitamin K involved in the normal production of several proteins needed for blood coagulation. Injectable preparations may be used when vitamin K replacement is medically indicated and an appropriate injectable formulation is available.

The reason for treatment, preparation, route of administration and monitoring requirements depend on the patient's age, condition and clinical assessment.

Uses of K1 KAND Injection

Depending on the exact formulation and the clinician's assessment, injectable phytomenadione may be used for:

• Prevention or treatment of vitamin K deficiency-related bleeding in newborns when indicated.
• Treatment of certain blood-clotting abnormalities caused by vitamin K deficiency.
• Correction of selected clotting problems associated with medicines that interfere with vitamin K activity, under specialist supervision.
• Selected conditions that reduce vitamin K absorption or availability, when injectable replacement is clinically appropriate.

Not every vitamin K1 product is approved or suitable for every use. The exact product label and local prescribing guidance must be followed.

Benefits / Potential Benefits

• Provides vitamin K1 when replacement is medically required.
• Supports the body's production of vitamin K-dependent clotting factors.
• May help correct certain clotting abnormalities caused by vitamin K deficiency.
• Can be used in specific newborn-care protocols to prevent vitamin K deficiency bleeding.

The effect and speed of response depend on the underlying cause, the patient's condition and the prescribed treatment plan. It is not a general-purpose treatment for every type of bleeding.

Possible Side Effects

Side effects vary by formulation and route. Report any unusual symptoms to the healthcare professional promptly.

• Pain, swelling or a reaction at the injection site.
• Flushing, sweating, dizziness or changes in blood pressure.
• Rapid heartbeat, chest discomfort or breathing difficulty.
• Skin reactions or signs of an allergic reaction.
• Rare but serious hypersensitivity reactions, including anaphylaxis, have been reported with injectable phytonadione, particularly with intravenous or intramuscular administration.

How to Use K1 KAND Injection

• Use only when prescribed or directed by an appropriately qualified healthcare professional.
• Administration must be performed by trained healthcare personnel according to the exact product instructions.
• The dose and route depend on the indication, age, clinical condition, laboratory results and labelled formulation.
• Do not self-inject, change the dose or repeat a dose without medical advice.
• Blood-clotting tests and clinical monitoring may be needed to assess the response.

The supplied information does not establish a specific strength, route or dosage for K1 KAND Injection. These details must be verified before administration.

How It Works

Vitamin K1 helps the liver produce functional forms of certain clotting proteins, including factors II, VII, IX and X, as well as proteins C and S. These proteins contribute to normal blood coagulation.

When a clotting problem is caused by vitamin K deficiency or interference with vitamin K activity, appropriate replacement may help restore clotting-factor function. It will not correct bleeding caused by every possible underlying condition.

Safety Advice

• Allergies: Tell the healthcare professional about any previous reaction to vitamin K products or formulation ingredients.
• Other medicines: Report all medicines, especially warfarin and other anticoagulants. Vitamin K can alter the effect of vitamin K-antagonist anticoagulants and requires appropriate monitoring.
• Administration risks: Injectable phytonadione can cause serious hypersensitivity reactions. Route selection and administration must follow the specific product's warnings and clinical guidance.
• Pregnancy and breastfeeding: Inform the treating clinician so that the need for treatment and formulation can be assessed.
• Newborns and children: Use only the appropriate formulation and a clinician-directed regimen.
• Monitoring: Follow recommended blood tests and clinical review. Do not adjust anticoagulant treatment independently.

Quick Tips

• Check the product name, concentration, vial volume, expiry date and packaging before use.
• Do not assume the strength from the brand name alone.
• Tell the healthcare professional about bleeding symptoms and all current medicines.
• Keep the product stored according to its own label and protect it from unsuitable storage conditions.
• Never use a damaged, contaminated or expired injection.
• Seek urgent care for uncontrolled bleeding, black stools, vomiting blood or sudden severe headache, regardless of whether vitamin K has been given.